Pembrolizumab + axitinib beyond first-line therapy for mRCC

Nature Reviews Urology, Published online: 16 February 2023; doi:10.1038/s41585-023-00743-0Pembrolizumab + axitinib beyond first-line therapy for mRCC

Source: Nature Reviews Urology - February 16, 2023 Category: Urology & Nephrology Authors: Tim Thomas Source Type: research